Hypophosphatemic Rickets with Hypercalciuria (HHRH)

Last updated: February 8, 2026Reviewed date: February 8, 2026Reading time: 22 min read
Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Article Summary

Hypophosphatemic rickets with hypercalciuria (HHRH) is a rare, inherited bone and kidney disorder. The kidneys spill too much phosphate into urine (phosphate wasting). Because phosphate is low in blood, growing bones cannot mineralize well, so children develop rickets (soft, weak bones) and adults can get osteomalacia (bone pain, fractures). Unlike many other forms of hypophosphatemic rickets, HHRH typically has high urinary calcium (hypercalciuria) and often...

Key Takeaways

  • This article explains Other names in simple medical language.
  • This article explains Types in simple medical language.
  • This article explains Causes in simple medical language.
  • This article explains Symptoms in simple medical language.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Fever with very low white blood cells or known immune suppression.
  • Unusual bruising, persistent bleeding, black stools, or severe weakness.
  • Shortness of breath, fainting, confusion, or rapidly worsening fatigue.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

Hypophosphatemic rickets with hypercalciuria (HHRH) is a rare, inherited bone and kidney disorder. The kidneys spill too much phosphate into urine (phosphate wasting). Because phosphate is low in blood, growing bones cannot mineralize well, so children develop rickets (soft, weak bones) and adults can get osteomalacia (bone pain, fractures). Unlike many other forms of hypophosphatemic rickets, HHRH typically has high urinary calcium (hypercalciuria) and often high levels of active vitamin D (1,25-dihydroxyvitamin D), which raises the risk of kidney stones or nephrocalcinosis. Most cases come from loss-of-function variants in the SLC34A3 gene (also called NaPi-IIc), inherited in an autosomal recessive way. ScienceDirect+4PubMed+4ScienceDirect+4 The SLC34A3/NaPi-IIc transporter in the kidney’s proximal tubule normally brings phosphate back into the body. When it does not work, phosphate is lost in urine → blood phosphate falls → bones do not mineralize → rickets/osteomalacia. The body responds by making more active vitamin D (1,25-OH₂D) to absorb more calcium and phosphate from food. That extra calcium is filtered into urine, causing hypercalciuria and sometimes stones. HHRH usually has low or normal FGF23 (unlike XLH), which is another way to distinguish it. PubMed+2PMC+2

Hypophosphatemic rickets with hypercalciuria—often shortened to HHRH—is a rare genetic disorder where the kidneys waste too much phosphate (a mineral bones need). Because phosphate keeps slipping out in the urine, blood phosphate stays low. The body tries to “fix” this by making extra active vitamin D [1,25-(OH)₂D]. That raises calcium absorption from the gut, so calcium in the urine becomes high (hypercalciuria). Children can develop rickets (soft, poorly mineralized bones); teens and adults may have bone pain, short height, and kidney stones or calcium deposits in the kidneys (nephrocalcinosis). Unlike most other hypophosphatemic rickets, HHRH is FGF23-independent (FGF23 is normal or low) and is caused most often by biallelic variants in SLC34A3 (NaPi-IIc), a phosphate transporter in the kidney’s proximal tubule. OUP Academic+2ScienceDirect+2

Key physiology in one line: kidney phosphate wasting → low serum phosphate → low FGF23 & high 1,25-(OH)₂D → increased gut calcium absorption → hypercalciuria ± kidney stones. PMC+1

Other names

  • HHRH

  • Hereditary hypophosphatemic rickets with hypercalciuria (OMIM 241530)

  • NaPi-IIc (SLC34A3)–related hypophosphatemic rickets

  • FGF23-independent hereditary hypophosphatemic rickets

  • Non-FGF23 hypophosphatemic rickets with hypercalciuria
    These labels all point to the same core picture: renal phosphate wasting with high 1,25-(OH)₂D and hypercalciuria due to SLC34A3 dysfunction. ScienceDirect+1

Types

1) Classic biallelic SLC34A3 HHRH. Children with two harmful SLC34A3 variants develop hypophosphatemic rickets, high 1,25-(OH)₂D, and hypercalciuria, sometimes with nephrolithiasis or nephrocalcinosis. OUP Academic

2) Partial/heterozygous SLC34A3. Some people with a single variant can have milder features such as kidney stones and hypercalciuria without obvious rickets; families show a spectrum. PubMed

3) SLC34A1 (NaPi-IIa)–related phosphate wasting (HHRH-like). Variants in SLC34A1 can also cause renal phosphate wasting with rickets and hypercalciuria, sometimes labeled as a phenocopy of HHRH. New England Journal of Medicine

4) Age-at-presentation variants. Some patients present in early childhood with bowing legs; others are found later with bone pain or kidney stones discovered on imaging. Merck Manuals

Causes

HHRH has one main cause—pathogenic variants in SLC34A3. The list below explains that root cause in detail (different mutation patterns), plus well-documented look-alikes and modifiers that can produce a similar picture of “hypophosphatemic rickets with hypercalciuria” or can worsen it. I clearly note which are primary causes and which are phenocopies/modifiers.

  1. Biallelic SLC34A3 loss-of-function (primary). Most classic HHRH results from two damaging variants in SLC34A3; the kidney cannot reclaim phosphate → low serum phosphate, high 1,25-(OH)₂D, hypercalciuria. ScienceDirect+1

  2. Compound heterozygous SLC34A3 variants (primary). Two different harmful changes—one on each allele—produce the same physiology and clinical picture. PMC

  3. Homozygous SLC34A3 missense variants (primary). A single amino-acid change on both copies can inactivate NaPi-IIc enough to cause full HHRH. PMC

  4. Homozygous nonsense/frameshift SLC34A3 variants (primary). Truncating mutations can abolish transporter function, leading to severe renal phosphate wasting. PMC

  5. SLC34A3 splice-site variants (primary). Splicing defects disrupt protein making, again causing phosphate loss. PMC

  6. Large deletions/insertions in SLC34A3 (primary). Structural variants that remove critical exons lead to HHRH. PMC

  7. Promoter/regulatory SLC34A3 variants (primary, rarer). Reduced gene expression can lower transporter amount and cause HHRH. (Described in variant series.) PMC

  8. SLC34A3 variants with kidney-predominant features (primary). Some families present mainly with stones/hypercalciuria and only subtle bone disease. ScienceDirect

  9. SLC34A1 (NaPi-IIa) pathogenic variants (phenocopy). NaPi-IIa loss can also cause renal phosphate wasting with rickets and hypercalciuria, mimicking HHRH. New England Journal of Medicine

  10. Dent disease (CLCN5/OCRL) (phenocopy). X-linked proximal tubulopathy that can produce hypophosphatemic rickets and hypercalciuria—but with low-molecular-weight proteinuria and other tubular losses (clues against HHRH). PMC+1

  11. Fanconi syndrome from medications (phenocopy). Proximal tubular injury (e.g., from tenofovir disoproxil fumarate) causes phosphate wasting and osteomalacia; some cases show hypercalciuria. PMC+1

  12. Inherited Fanconi syndromes (phenocopy). Genetic proximal tubular disorders (e.g., X-linked forms) can cause rickets via phosphate loss; hypercalciuria may occur. PMC

  13. High dietary sodium (modifier). High sodium intake increases urinary calcium loss and can worsen hypercalciuria in people with renal phosphate wasting. NCBI

  14. High calcium or vitamin D supplementation (modifier). Extra calcium or active vitamin D raises urinary calcium and may exacerbate stones in HHRH (calcitriol is generally avoided in HHRH). PubMed+1

  15. Dehydration/low fluid intake (modifier). Concentrated urine raises stone risk in patients with hypercalciuria. NCBI

  16. Reduced phosphate intake (modifier). Low phosphate diet further lowers serum phosphate and can aggravate rickets. (Background hypophosphatemia physiology.) NCBI

  17. Pregnancy/lactation stress on minerals (modifier). Mineral demands change; in predisposed individuals, urinary calcium can rise and stones may appear. (General hypercalciuria/stone risk physiology.) NCBI

  18. Renal calcifications themselves (vicious cycle). Nephrocalcinosis can reduce tubular function over time and worsen losses. (Stone/hypercalciuria literature.) NCBI

  19. Other proximal tubule toxins (phenocopy). Ifosfamide and some antivirals/antibiotics can cause acquired Fanconi-type phosphate wasting with rickets. PMC

  20. Mis-treatment with calcitriol in unrecognized HHRH (iatrogenic aggravator). Active vitamin D is standard in FGF23-driven rickets but worsens hypercalciuria in HHRH; correct diagnosis matters. PMC+1

Symptoms

  1. Bowing of legs or knock-knees. Soft, undermineralized bone in growing children bends under body weight, producing visible deformities. Merck Manuals

  2. Wrist and knee swelling. Wide growth plates and metaphyseal changes feel “spongy” or enlarged on exam in active rickets. Merck Manuals

  3. Delayed growth and short height. Chronic phosphate shortage slows bone growth, leading to short stature if untreated. Merck Manuals

  4. Bone pain and tenderness. Poorly mineralized bone and micro-fractures cause aching pain, often in legs or ribs. Merck Manuals

  5. Muscle weakness or fatigue. Low phosphate impairs energy (ATP) use in muscle; children may tire easily or have trouble climbing stairs. NCBI

  6. Delayed walking or motor milestones. Weak bones and muscles slow gross motor development. Merck Manuals

  7. Waddling gait. Hip and leg deformities alter walking pattern. Merck Manuals

  8. Tooth problems. Hypomineralized dentin can mean fragile teeth, caries, or abscesses in some forms of hypophosphatemic rickets. (General rickets literature.) Nature

  9. Kidney stones. Extra urinary calcium can crystallize and form painful stones, sometimes the first adult sign. OUP Academic

  10. Nephrocalcinosis. Calcium deposits inside kidney tissue show up on ultrasound and may reduce kidney function over years. OUP Academic

  11. Frequent urination or urgency. Stones or tubular dysfunction can irritate the urinary tract. (Stone/hypercalciuria data.) NCBI

  12. Fractures or pseudofractures. Poor bone mineralization raises the risk of breaks with minor trauma. Merck Manuals

  13. pain: Back pain means pain in the spine, muscles, discs, joints, or nerves of the back. সহজ বাংলা: পিঠ/কোমরের ব্যথা।" data-rx-term="back pain" data-rx-definition="Back pain means pain in the spine, muscles, discs, joints, or nerves of the back. সহজ বাংলা: পিঠ/কোমরের ব্যথা।">Back pain. Vertebral involvement or stones can cause persistent back discomfort. (Bone/stone literature.) NCBI

  14. Normal or low-normal calcium in blood. Calcium in the urine is high, but blood calcium is often normal because of high 1,25-(OH)₂D. PMC

  15. No obvious FGF23-type signs. Unlike FGF23-driven rickets, HHRH tends to show low/normal FGF23 and high 1,25-(OH)₂D. PMC

Diagnostic tests

A) Physical examination

  1. Growth and body proportions. Measure height/weight and compare with age charts; chronic hypophosphatemia stunts growth. Merck Manuals

  2. Limb alignment check. Look for genu varum/valgum (bowing/knock-knees) and anterior tibial curvature, classic for rickets. Merck Manuals

  3. Wrist, knee, and costochondral palpation. Widened wrists/knees and a “rachitic rosary” at the rib ends are common in active rickets. Merck Manuals

  4. Gait assessment. Waddling gait or pain with walking often reflects lower-limb deformity and bone tenderness. Merck Manuals

B) Simple manual/bedside maneuvers

  1. Shin and rib pain when an area is touched or pressed. সহজ বাংলা: চাপ দিলে ব্যথা।" data-rx-term="tenderness" data-rx-definition="Tenderness means pain when an area is touched or pressed. সহজ বাংলা: চাপ দিলে ব্যথা।">tenderness testing. Gentle pressure can reproduce pain where undermineralized bone is stressed. Merck Manuals

  2. Functional strength tests. Sit-to-stand or stair-climb performance helps gauge muscle weakness from phosphate deficiency. NCBI

  3. Dental inspection. Look for enamel or dentin defects and early caries that suggest chronic mineralization problems. Nature

C) Laboratory and pathological tests

  1. Serum phosphate (low). Persistent hypophosphatemia is the biochemical hallmark. Use age-specific ranges in children. NCBI

  2. Serum calcium (often normal). Despite high urine calcium, blood calcium is usually normal in HHRH. PMC

  3. Alkaline phosphatase (elevated). Reflects high bone turnover in active rickets/osteomalacia. Wiley Online Library

  4. 1,25-(OH)₂D (elevated). High active vitamin D distinguishes HHRH from FGF23-driven rickets (where it’s low/normal). ScienceDirect

  5. FGF23 (low/normal). Helps point to a non-FGF23 mechanism like HHRH or Fanconi. PMC+1

  6. Urine calcium (elevated). Spot calcium/creatinine ratio or 24-hour urine confirms hypercalciuria; stone risk correlates with this. NCBI

  7. Renal phosphate handling (TmP/GFR). Calculating tubular maximum phosphate reabsorption per GFR confirms renal phosphate wasting. OUP Academic

  8. Genetic testing (SLC34A3 ± SLC34A1). Identifies pathogenic variants and clarifies family risk; guides correct therapy (avoid calcitriol). ScienceDirect+1

D) Electrodiagnostic tests

  1. Electromyography (optional). In marked hypophosphatemia with muscle symptoms, EMG can show myopathic changes; used when weakness is prominent. NCBI

  2. Electrocardiogram (optional). Severe electrolyte disturbances can rarely affect rhythm; ECG is prudent in symptomatic or severely depleted patients. NCBI

E) Imaging

  1. Skeletal X-rays. Show widened growth plates, metaphyseal cupping/fraying, and Looser zones/pseudofractures in osteomalacia. Merck Manuals

  2. Renal ultrasound. Screens for nephrocalcinosis and stones, common with long-standing hypercalciuria. OUP Academic

  3. Bone density (DXA) or bone age. Assesses overall mineralization and growth delay; useful for monitoring recovery on treatment. Merck Manuals

Non-pharmacological treatments (therapies & daily measures)

  1. Regular, divided meals with phosphate-containing foods – Purpose: support bone mineralization alongside prescribed phosphate. Mechanism: each meal delivers small phosphate amounts that the gut can absorb; small frequent dosing matches how medical phosphate is also given. ec.bioscientifica.com

  2. High-fluid intake (≥2 L/day for older children/adults, as allowed by your clinician) – Purpose: dilute urine to lower stone risk. Mechanism: more water lowers calcium/phosphate concentration in urine so crystals are less likely to form. ScienceDirect

  3. Salt restriction – Purpose: reduce urinary calcium loss and stone risk. Mechanism: less sodium intake reduces calcium excretion in the distal nephron, which can lower hypercalciuria. FDA Access Data

  4. Balanced calcium (not high-dose) diet – Purpose: maintain normal calcium without driving extra urine calcium. Mechanism: steady dietary calcium supports bone but avoids large surges that can increase calciuria in HHRH. PMC

  5. Avoid unnecessary active vitamin D (calcitriol/alfacalcidol) unless your specialist explicitly prescribes it – Purpose: prevent worsening hypercalciuria and stones. Mechanism: active vitamin D raises intestinal calcium absorption → more urinary calcium; in HHRH it’s often already high. PMC+1

  6. Fracture-safe physical activity (weight-bearing as tolerated) – Purpose: build bone and muscle safely. Mechanism: gentle loading stimulates bone formation; programs are adapted to rickets/osteomalacia to reduce fracture risk. ec.bioscientifica.com

  7. Physiotherapy for alignment, gait, and muscle strength – Purpose: ease pain, improve function during bone healing. Mechanism: targeted exercises improve joint mechanics while bones mineralize under treatment. ec.bioscientifica.com

  8. Orthotics / guided bracing in growing children – Purpose: support limb alignment while rickets heals. Mechanism: controlled mechanical support reduces deforming forces on soft bone. ec.bioscientifica.com

  9. Stone prevention education (timed voiding, avoiding dehydration during fevers/exercise) – Purpose: practical habits that cut stone risk. Mechanism: frequent urination and hydration lower dwell time and supersaturation of crystals. ScienceDirect

  10. Nutrition counseling – Purpose: match daily phosphate, calcium, and protein targets with medical therapy. Mechanism: individualized plans optimize bone mineralization and kidney health. ec.bioscientifica.com

  11. Monitoring plan (labs & ultrasound) – Purpose: catch complications early. Mechanism: periodic tests (phosphate, calcium, 1,25-OH₂D, urine calcium/creatinine) and renal imaging guide dose adjustments. PMC

  12. Low-oxalate choices if stones are an issue – Purpose: reduce calcium oxalate stone formation. Mechanism: less oxalate in diet lowers urinary oxalate load and crystal formation with calcium. ScienceDirect

  13. Maintain a healthy BMI – Purpose: decrease stone risk and joint stress. Mechanism: weight control improves urinary chemistry and reduces mechanical load on healing bones. ScienceDirect

  14. Limit high-sugar sodas – Purpose: they may increase urinary calcium and stone risk. Mechanism: certain soft drinks alter urinary chemistry in ways that favor stones. ScienceDirect

  15. Sunlight in moderation (for baseline vitamin D only) – Purpose: support normal 25-OH-D without overshooting active vitamin D. Mechanism: skin vitamin D becomes 25-OH-D; clinicians keep it normal while avoiding extra calcitriol. PMC

  16. School and sports accommodations – Purpose: prevent injury during active rickets. Mechanism: adjust PE loads and allow hydration breaks to lower fracture and stone risk. ec.bioscientifica.com

  17. Pain-coping skills & sleep hygiene – Purpose: manage chronic bone pain, improve quality of life. Mechanism: behavioral techniques reduce pain amplification and improve function. ec.bioscientifica.com

  18. Family genetic counseling – Purpose: understand inheritance and testing of siblings. Mechanism: explains autosomal recessive risk and identifies heterozygous carriers who can have milder hypercalciuria. PMC

  19. Sick-day hydration plan – Purpose: avoid dehydration-triggered stone events. Mechanism: replacing fluids during illness keeps urine dilute. ScienceDirect

  20. Shared-care team (endocrine + nephrology + genetics + dietetics + physio) – Purpose: coordinate safe phosphate therapy and protect kidneys. Mechanism: team review ensures balance between bone healing and stone prevention. PMC+1

Drug treatments

Important: HHRH is not treated like XLH. In HHRH, clinicians usually give oral phosphate alone and avoid routine calcitriol, because calcitriol can worsen hypercalciuria and stones. Thiazide-type diuretics and potassium citrate may be added for kidney stone prevention if needed. Always dose and monitor with your specialist. PMC+1

  1. Oral neutral phosphate salts (e.g., Phospha 250 Neutral) – Class: phosphate replacement. Dose/time: typically divided 3–5 times daily; the specific brand’s labeling guides tablet strength. Purpose & mechanism: directly restores blood phosphate so bones mineralize; lowers compensatory 1,25-OH₂D over time. Safety: GI upset possible; monitor calcium, phosphate, and kidneys. FDA materials describe composition/strengths. FDA Access Data

  2. Potassium phosphates injection (hospital use) – Class: parenteral phosphate. Dose/time: IV infusion per labeling when oral/enteral replacement is not possible (e.g., severe symptomatic hypophosphatemia). Purpose & mechanism: rapidly corrects low phosphate. Safety: monitor electrolytes (phosphate, potassium, calcium, magnesium) and ECG during infusion. FDA Access Data+1

  3. Hydrochlorothiazide – Class: thiazide diuretic. Typical dose/time: commonly 12.5–25 mg once daily (hypertension label); dosing for hypercalciuria is individualized. Purpose & mechanism: reduces urinary calcium; helps prevent stones from HHRH-related hypercalciuria. Key safety: can lower potassium and raise uric acid; monitor electrolytes. FDA Access Data

  4. Chlorthalidone – Class: thiazide-like diuretic. Typical dose/time: 12.5–25 mg daily (per hypertension labels). Purpose/mechanism: long-acting option to reduce urinary calcium; chosen when hypercalciuria persists. Safety: watch for hypokalemia, volume depletion. FDA Access Data+1

  5. Indapamide – Class: thiazide-like diuretic. Typical dose/time: 1.25–2.5 mg daily (label). Purpose/mechanism: alternative when HCTZ/chlorthalidone not tolerated. Safety: similar electrolyte risks; monitor. FDA Access Data+1

  6. Amiloride – Class: potassium-sparing diuretic. Typical dose/time: 5–10 mg daily (label for hypertension/diuretic-induced hypokalemia). Purpose/mechanism: often combined with a thiazide to limit potassium loss and may modestly reduce urinary calcium. Safety: risk of hyperkalemia; avoid with kidney failure. FDA Access Data

  7. Potassium citrate (Urocit-K) – Class: urinary alkalinizer/citrate. Typical dose/time: titrated to reach normal urinary citrate; label instructs pairing with low-salt diet and high fluids. Purpose/mechanism: citrate binds urinary calcium and inhibits calcium oxalate crystal growth, lowering stone risk in hypercalciuria. Safety: GI upset, hyperkalemia risk with certain drugs. FDA Access Data+1

  8. Pain control (short-term acetaminophen under supervision) – Class: analgesic. Purpose/mechanism: symptom relief during active rickets while bone heals on phosphate therapy. Safety: follow package/clinician guidance for liver-safe dosing. (General standard; no FDA label citation needed beyond drug labeling norms.)

  9. Avoid routine calcitriol (Rocaltrol) in HHRH – Why listed: many rickets types require calcitriol, but HHRH usually does not. Mechanism/purpose: in HHRH, endogenous 1,25-OH₂D is often already high; exogenous calcitriol would further raise urinary calcium. If ever used, it should be for specific indications under expert care with close urine calcium monitoring. Label note: calcitriol is FDA-approved vitamin D; this is a caution, not a recommendation. FDA Access Data+1

  10. Citrate during thiazide therapy (adjunct) – Purpose/mechanism: when thiazides reduce urine calcium but citrate is still low, adding potassium citrate further reduces stone risk. Safety & dosing: per Urocit-K label; individualized targets. FDA Access Data

  11. Electrolyte monitoring and repletion (e.g., potassium chloride as needed) – Purpose/mechanism: corrects thiazide-induced hypokalemia to maintain safety and treatment effectiveness. Label note: potassium chloride has detailed FDA labeling; clinicians dose to lab targets. FDA Access Data

  12. Sodium restriction alongside thiazide – Purpose/mechanism: enhances anticalciuric effect of thiazides and reduces stone risk; implemented with or without Urocit-K per label guidance. FDA Access Data

  13. Intravenous phosphate only when necessary – Purpose: rescue therapy for severe cases unable to take oral. Mechanism/safety: as above with potassium phosphates labeling. FDA Access Data

Additional prescription options are rarely required specifically for HHRH beyond the combinations above. Management focuses on oral phosphate, stone prevention (thiazide ± citrate, fluids, salt restriction), and careful monitoring; disease-specific biologics used for other rickets (e.g., burosumab for XLH) are not indicated in HHRH. NCBI

Dietary molecular supplements

These are adjuncts only. They do not replace medical phosphate or stone-prevention medicines. Always check interactions and labs with your clinician.

  1. Citrate (as potassium citrate) – Function: raises urinary citrate, a natural stone inhibitor; may reduce calcium oxalate crystal formation. Mechanism: citrate binds calcium and alkalinizes urine. Dose: per Urocit-K label and clinic target. FDA Access Data

  2. Magnesium (dietary / supplement, if low) – Function: low magnesium can worsen stone risk; normalizing helps. Mechanism: magnesium complexes with oxalate and reduces crystal formation. Dose: individualized by clinician. ScienceDirect

  3. Adequate dietary calcium (avoid excess) – Function: supports bone; binds oxalate in gut. Mechanism: normal calcium intake reduces oxalate absorption. Dose: age-appropriate dietary targets. PMC

  4. Phosphate-rich foods aligned with dosing plan – Function: complements divided phosphate therapy. Mechanism: small meal-time phosphate inputs support bone. ec.bioscientifica.com

  5. Vitamin D (nutritional 25-OH-D only, if low) – Function: keep 25-OH-D in the normal range; avoid active vitamin D excess. Mechanism: supports general bone health without driving hypercalciuria. Dose: clinician-guided repletion to normal. PMC

  6. Citrate-containing beverages (e.g., lemon water without sugar) – Function: modestly raises urinary citrate. Mechanism: alkali citrate intake can inhibit crystal growth. ScienceDirect

  7. Low-oxalate choices when stones are calcium oxalate – Function: decreases urinary oxalate. Mechanism: less oxalate → fewer crystals with calcium. ScienceDirect

  8. Adequate protein, not high-protein – Function: supports growth and repair. Mechanism: excessive animal protein can increase calciuria/acid load; balanced intake avoids that. ScienceDirect

  9. Limit added sugars/sodas – Function: reduces stone risk and supports healthy weight. Mechanism: sugary sodas are associated with stone-promoting urine chemistry. ScienceDirect

  10. Sodium reduction – Function: lowers urinary calcium. Mechanism: less sodium reabsorption trade-off reduces calciuria. FDA Access Data

Immunity booster / regenerative / stem cell drugs

There are no FDA-approved “immunity booster,” regenerative, or stem-cell drugs for HHRH. HHRH is a transporter defect of renal phosphate handling; management is replacement of phosphate and prevention of kidney complications. Using unproven “regenerative” or stem-cell products would be unsafe and is not recommended. FDA-approved phosphate products and thiazide/citrate labels above are the relevant drug sources. FDA Access Data+1

Surgeries

  1. Orthopedic guided growth/osteotomy – Procedure to correct severe limb bowing or torsion if bracing and medical therapy are insufficient. Why: restores alignment for function and pain relief during/after bone healing. ec.bioscientifica.com

  2. Ureteroscopy for obstructing stones – Endoscopic laser fragmentation and removal when a stone blocks urine flow. Why: relieves pain/obstruction from HHRH-related stones. ScienceDirect

  3. Percutaneous nephrolithotomy – Keyhole removal of large kidney stones. Why: clears heavy stone burden (nephrocalcinosis with big stones). ScienceDirect

  4. Shock-wave lithotripsy – External shock waves break stones into passable pieces. Why: treats selected stones depending on size and location. ScienceDirect

  5. Corrective procedures for deformities affecting mobility – Tailored orthopedic operations if persistent deformities impair walking despite medical therapy. Why: improves quality of life. ec.bioscientifica.com

Preventions

  • Take phosphate exactly as prescribed, in divided doses to keep blood phosphate steady and support bone. ec.bioscientifica.com

  • Drink plenty of water every day to dilute urine and prevent stones. ScienceDirect

  • Limit salt to reduce urinary calcium. FDA Access Data

  • Do not take calcitriol unless your specialist prescribes it for a special reason, because it can worsen hypercalciuria in HHRH. PMC

  • Follow a stone-smart diet (adequate calcium, lower oxalate, minimal sugary soda). ScienceDirect

  • Keep 25-OH-vitamin D in the normal range (not high). PMC

  • Use thiazide ± potassium citrate if your doctor recommends them for persistent hypercalciuria. FDA Access Data+1

  • Attend regular lab and ultrasound checks to adjust doses early. PMC

  • Protect bones with safe activity and physiotherapy during healing. ec.bioscientifica.com

  • Plan for illness/heat with extra fluids to avoid concentrated urine. ScienceDirect

When to see a doctor

  • New or worsening bone pain, bowing, limping, or fractures → clinic/ED review. PMC

  • Kidney stone symptoms (severe flank pain, blood in urine, fever, vomiting, trouble passing urine) → urgent care/ER. ScienceDirect

  • Signs of electrolyte problems on thiazides (muscle cramps, weakness, light-headedness) → prompt labs. FDA Access Data

  • If pregnant or planning pregnancy → preconception counseling for genetic risk and medication review. PMC

  • Any time doses change (phosphate, thiazide, citrate) → monitoring plan update. PMC

What to eat & what to avoid

  • Eat: normal-calcium foods (milk/yogurt in usual amounts), legumes/lean meats for protein, fruits/vegetables (many provide potassium/citrate), whole grains, and plenty of water across the day. ScienceDirect

  • Avoid/limit: very salty foods (chips, processed meats), sugary sodas/colas, excessive animal protein, large single boluses of calcium or vitamin D supplements without medical advice, and dehydration (especially in heat/exercise). ScienceDirect

FAQs

1) How is HHRH different from the common X-linked rickets (XLH)?
HHRH has hypercalciuria and typically high 1,25-OH₂D with low/normal FGF23; XLH has low 1,25-OH₂D with high FGF23 and usually normal urine calcium. NCBI

2) What gene is involved?
Most HHRH is due to SLC34A3 (NaPi-IIc) variants. PubMed

3) Is calcitriol helpful?
Usually no—it can worsen hypercalciuria in HHRH; treatment usually focuses on oral phosphate. PMC

4) Why do kidney stones happen?
Extra active vitamin D increases gut calcium absorption → more urinary calcium → stones/nephrocalcinosis. PMC

5) Do carriers have symptoms?
Some heterozygous carriers may have milder biochemical changes resembling idiopathic hypercalciuria. PMC

6) What tests confirm the diagnosis?
Low serum phosphate, high urinary phosphate wasting (low TmP/GFR), high 1,25-OH₂D, hypercalciuria, and SLC34A3 sequencing. PMC

7) How is phosphate taken?
Divided oral doses 3–5 times daily; dose is individualized and adjusted to labs and growth. ec.bioscientifica.com

8) Can thiazide pills help?
Yes—when hypercalciuria persists, thiazides (e.g., hydrochlorothiazide or chlorthalidone) reduce urinary calcium. FDA Access Data+1

9) Why add potassium citrate?
It raises urinary citrate, which binds calcium and slows crystal formation—a standard stone-prevention tool. FDA Access Data

10) Are there FDA-approved regenerative or stem-cell drugs for HHRH?
No; management relies on phosphate replacement and stone prevention, not regenerative drugs. FDA Access Data

11) Will my child’s bones get better?
With early diagnosis, correct phosphate therapy, and stone prevention, bones usually mineralize and pain/function improve. Monitoring continues through growth. PMC

12) Can HHRH be missed if vitamin D is low?
Yes—vitamin D deficiency can mask the typical pattern; once corrected, the characteristic labs (including hypercalciuria) re-appear. Kidney International+1

13) Do I need genetic counseling?
Helpful for family planning and sibling testing in this autosomal recessive condition. PMC

14) What imaging is needed?
Renal ultrasound for stones/nephrocalcinosis and X-rays for rickets/osteomalacia. ScienceDirect

15) Are XLH medicines (like burosumab) used here?
No—those target FGF23 excess (not the problem in HHRH). NCBI

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 07, 2025.

PDF Documents For This Disease Condition

  1. Rare Diseases and Medical Genetics.[rxharun.com]
  2. i2023_IFPMA_Rare_Diseases_Brochure_28Feb2017_FINAL.[rxharun.com]
  3. the-UK-rare-diseases-framework.[rxharun.com]
  4. National-Recommendations-for-Rare-Disease-Health-Care-Summary.[rxharun.com]
  5. History of rare diseases and their genetic.[rxharun.com]
  6. health-care-and-rare-disorders.[rxharun.com]
  7. Rare Disease Registries.[rxharun.com]
  8. autoimmune-Rare-Genetic-Diseases.[rxharun.com]
  9. Rare Genetic Diseases.[rxharun.com]
  10. rare-disease-day.[rxharun.com]
  11. Rare_Disease_Drugs_e.[rxharun.com]
  12. fda-CDER-Rare-Diseases-Public-Workshop-Master.[rxharun.com]
  13. rare-and-inherited-disease-eligibility-criteria.[rxharun.com]
  14. FDA-rare-disease-list.pdf-rxharun.com1 Human-Gene-Therapy-for-Rare Diseases_Jan_2020fda.[rxharun.com]
  15. FDA-rare-disease-lists.[rxharun.com]
  16. 30212783fnl_Rare Disease.[rxharun.com]
  17. FDA-rare-disease-list.[rxharun.com]
  18. List of rare disease.[rxharun.com]
  19. Genome Res.-2025-Steyaert-755-68.[rxharun.com]
  20. uk-practice-guidelines-for-variant-classification-v4-01-2020.[rxharun.com]
  21. PIIS2949774424010355.[rxharun.com]
  22. hidden-costs-2016.[rxharun.com]
  23. B156_CONF2-en.[rxharun.com]
  24. IRDiRC_State-of-Play-2018_Final.[rxharun.com]
  25. IRDR_2022Vol11No3_pp96_160.[rxharun.com]
  26. from-orphan-to-opportunity-mastering-rare-disease-launch-excellence.[rxharun.com]
  27. Rare disease fda.[rxharun.com]
  28. England-Rare-Diseases-Action-Plan-2022.[rxharun.com]
  29. SCRDAC 2024 Report.[rxharun.com]
  30. CORD-Rare-Disease-Survey_Full-Report_Feb-2870-2.[rxharun.com]
  31. Stats-behind-the-stories-Genetic-Alliance-UK-2024.[rxharun.com]
  32. rare-and-inherited-disease-eligibility-criteria-v2.[rxharun.com]
  33. ENG_White paper_A4_Digital_FINAL.[rxharun.com]
  34. UK_Strategy_for_Rare_Diseases.[rxharun.com]
  35. MalaysiaRareDiseaseList.[rxharun.com]
  36. EURORDISCARE_FULLBOOKr.[rxharun.com]
  37. EMHJ_1999_5_6_1104_1113.[rxharun.com]
  38. national-genomic-test-directory-rare-and-inherited-disease-eligibilitycriteria-.[rxharun.com]
  39. be-counted-052722-WEB.[rxharun.com]
  40. RDI-Resource-Map-AMR_MARCH-2024.[rxharun.com]
  41. genomic-analysis-of-rare-disease-brochure.[rxharun.com]
  42. List-of-rare-diseases.[rxharun.com]
  43. RDI-Resource-Map-AFROEMRO_APRIL[rxharun.com]
  44. rdnumbers.[rxharun.com] .
  45. Rare disease atoz .[rxharun.com]
  46. EmanPublisher_12_5830biosciences-.[rxharun.com]

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK208609/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6279436/
  3. https://rarediseases.org/rare-diseases/
  4. https://rarediseases.info.nih.gov/diseases
  5. https://en.wikipedia.org/w/index.php?title=Category:Rare_diseases
  6. https://en.wikipedia.org/wiki/List_of_genetic_disorders
  7. https://en.wikipedia.org/wiki/Category:Genetic_diseases_and_disorders
  8. https://medlineplus.gov/genetics/condition/
  9. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  10. https://www.fda.gov/patients/rare-diseases-fda
  11. https://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/support-clinical-trials-advancing-rare-disease-therapeutics-start-pilot-program
  12. https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2134
  13. https://www.mayoclinicproceedings.org/article/S0025-6196%2823%2900116-7/fulltext
  14. https://www.ncbi.nlm.nih.gov/mesh?
  15. https://www.rarediseasesinternational.org/working-with-the-who/
  16. https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03322-7
  17. https://www.rarediseasesnetwork.org/
  18. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-disease
  19. https://www.raregenomics.org/rare-disease-list
  20. https://www.astrazeneca.com/our-therapy-areas/rare-disease.html
  21. https://bioresource.nihr.ac.uk/rare
  22. https://www.roche.com/solutions/focus-areas/neuroscience/rare-diseases
  23. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  24. https://www.genomicsengland.co.uk/genomic-medicine/understanding-genomics/rare-disease-genomics
  25. https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
  26. https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01026
  27. https://wikicure.fandom.com/wiki/Rare_Diseases
  28. https://www.wikidoc.org/index.php/List_of_genetic_disorders
  29. https://www.medschool.umaryland.edu/btbank/investigators/list-of-disorders/
  30. https://www.orpha.net/en/disease/list
  31. https://www.genetics.edu.au/SitePages/A-Z-genetic-conditions.aspx
  32. https://ojrd.biomedcentral.com/
  33. https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/rare-diseases_en
  34. https://bioportal.bioontology.org/ontologies/ORDO
  35. https://www.orpha.net/en/disease/list
  36. https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions
  37. https://www.gao.gov/products/gao-25-106774
  38. https://www.gene.com/partners/what-we-are-looking-for/rare-diseases
  39. https://www.genome.gov/For-Patients-and-Families/Genetic-Disorders
  40. https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
  41. https://my.clevelandclinic.org/health/diseases/21751-genetic-disorders
  42. https://globalgenes.org/rare-disease-facts/
  43. https://www.nidcd.nih.gov/directory/national-organization-rare-disorders-nord
  44. https://byjus.com/biology/genetic-disorders/
  45. https://www.cdc.gov/genomics-and-health/about/genetic-disorders.html
  46. https://www.genomicseducation.hee.nhs.uk/doc-type/genetic-conditions/
  47. https://www.thegenehome.com/basics-of-genetics/disease-examples
  48. https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
  49. https://www.pfizerclinicaltrials.com/our-research/rare-diseases
  50. https://clinicaltrials.gov/ct2/results?recrs
  51. https://apps.who.int/gb/ebwha/pdf_files/EB116/B116_3-en.pdf
  52. https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239
  53. https://www.nibib.nih.gov/
  54. https://www.nei.nih.gov/
  55. https://oxfordtreatment.com/
  56. https://www.nidcd.nih.gov/health/https://consumer.ftc.gov/articles/
  57. https://www.nccih.nih.gov/health
  58. https://catalog.ninds.nih.gov/
  59. https://www.aarda.org/diseaselist/
  60. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets
  61. https://www.nibib.nih.gov/
  62. https://www.nia.nih.gov/health/topics
  63. https://www.nichd.nih.gov/
  64. https://www.nimh.nih.gov/health/topics
  65. https://www.nichd.nih.gov/
  66. https://www.niehs.nih.gov/
  67. https://www.nimhd.nih.gov/
  68. https://www.nhlbi.nih.gov/health-topics
  69. https://obssr.od.nih.gov/.
  70. https://www.nichd.nih.gov/health/topics
  71. https://rarediseases.info.nih.gov/diseases
  72. https://beta.rarediseases.info.nih.gov/diseases
  73. https://orwh.od.nih.gov/

 

Patient safety assistant

Check your symptom safely

Hi, I am RX Symptom Navigator. I can help you understand what to read next and what warning signs need care.
Warning: Do not use this in emergencies, pregnancy, severe illness, or as a substitute for a doctor. For children or teens, use with a parent/guardian and clinician.
A rural-friendly guide: warning signs, when to see a doctor, related articles, tests to discuss, and OTC safety education.
1 Symptom 2 Severity 3 Safe guidance
First safety question

Is there chest pain, breathing trouble, fainting, confusion, severe bleeding, stroke-like weakness, severe injury, or pregnancy danger sign?

Choose quickly

Browse by body area
Start here: Write or select a symptom. The guide will show warning signs, doctor guidance, diagnostic tests to discuss, OTC safety education, and related RX articles.

Important: This tool is educational only. It cannot diagnose, treat, or replace a doctor. OTC information is not a prescription. In an emergency, contact local emergency services or go to the nearest hospital.

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Orthopedic / spine specialist, physical medicine doctor, or qualified clinician
Tests to discuss with doctor
  • Neurological examination for leg power, sensation, reflexes, and straight leg raise
  • X-ray only if injury, deformity, long-lasting pain, or doctor suspects bone problem
  • MRI discussion if severe nerve symptoms, weakness, bladder/bowel problem, or persistent symptoms
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?
  • Is physiotherapy, posture correction, or activity modification needed?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Back pain care roadmap

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • New leg weakness, numbness around private area, or loss of bladder/bowel control
  • Back pain after major injury, fever, unexplained weight loss, cancer history, or severe night pain
Doctor / service to discuss: Orthopedic/spine specialist, physical medicine doctor, physiotherapist under guidance, or qualified clinician.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Discuss neurological examination first. X-ray or MRI may be needed only when red flags, injury, nerve weakness, or persistent severe symptoms are present.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.
  • Avoid forceful massage or bone-setting when there is weakness, injury, fever, or nerve symptoms.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area from the RX Article Professional Blocks panel.

More from this topic
  1. Congenital Epstein–Barr Virus Infection

    Congenital? Epstein–Barr virus infection? means a baby is thought to get Epstein–Barr virus, or EBV, before birth while still inside the mother’s womb. EBV is also...

    April 4, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  2. Mother-to-Child Transmission of Enterovirus Infection

    Mother-to-child transmission of enterovirus infection? means an enterovirus infection? passes from a pregnant mother to her baby before birth, during labor, at the time of delivery,...

    April 4, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  3. Congenital Enterovirus Infectious Disease

    Congenital? enterovirus infectious disease means an enterovirus infection? that is already present in the baby before birth or becomes apparent at birth or in the first...

    April 4, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  4. Congenital Enterovirus Infection

    Congenital? enterovirus infection? means a baby is infected with an enterovirus before birth or around the time of birth from the mother. In very simple words,...

    April 3, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  5. Congenital Enterocyte Heparan Sulfate Deficiency

    Congenital? enterocyte heparan sulfate deficiency is a real but ultra-rare genetic intestinal disease. It causes the small-intestine lining cells, called enterocytes, to lack heparan sulfate on...

    April 3, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  6. Congenital Dyserythropoietic Anemia Type 4

    Congenital? dyserythropoietic anemia? type 4, often called CDA type IV, is a very rare inherited red blood cell disorder linked to KLF1 dysfunction. In this disease,...

    April 1, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  7. Congenital Dyserythropoietic Anemia

    Congenital? dyserythropoietic anemia?, or CDA, is a rare inherited blood disease. In this disease, the bone marrow makes red blood cells in an abnormal way. Many...

    April 1, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  8. Congenital Dyshaematopoietic Anemia

    Congenital? dyshaematopoietic anemia? is more commonly called congenital? dyserythropoietic anemia?, or CDA. It is a rare inherited blood disorder. In this disease, the bone marrow makes...

    April 1, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  9. Congenital Dyserythropoietic Anemia

    Congenital? dyserythropoietic anemia?, often called CDA, is a rare inherited blood disorder. In this disease, the bone marrow makes red blood cells in an abnormal way....

    April 1, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)
  10. Carbohydrate-Deficient Glycoprotein Syndrome Type IE

    Carbohydrate-deficient glycoprotein syndrome type Ie is an old name for DPM1-congenital? disorder of glycosylation, often written as DPM1-CDG. It is a very rare inherited metabolic disease....

    April 1, 2026 • Rx Blood, Metabolism, and Infectious Diseases (A - Z)